Scarica l'app Stockscreener
3.28
2.38%
-0.08
Pre-mercato:
3.31
0.03
+0.91%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MNKD Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.36
Aprire:
$3.34
Volume 24 ore:
5.51M
Relative Volume:
0.88
Capitalizzazione di mercato:
$1.01B
Reddito:
$348.97M
Utile/perdita netta:
$5.86M
Rapporto P/E:
195.24
EPS:
0.0168
Flusso di cassa netto:
$13.69M
1 W Prestazione:
+14.69%
1M Prestazione:
+27.63%
6M Prestazione:
-37.52%
1 anno Prestazione:
-31.81%
Intervallo 1D:
$3.245
$3.43
Intervallo di 1 settimana:
$3.245
$4.29
Portata 52W:
$2.23
$6.51
Mannkind Corp Stock (MNKD) Company Profile
Nome
Mannkind Corp
Settore
Industria
Telefono
818-661-5000
Indirizzo
1 CASPER STREET, DANBURY, CA
Compare MNKD vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MNKD
Mannkind Corp
|
3.28 | 1.04B | 348.97M | 5.86M | 13.69M | 0.0168 |
VRTX
Vertex Pharmaceuticals Inc
|
448.29 | 110.45B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
723.41 | 74.73B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
812.81 | 50.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
292.03 | 38.03B | 4.29B | 577.22M | 641.34M | 4.2086 |
ONC
Beone Medicines Ltd Adr
|
315.07 | 32.24B | 5.76B | 514.49M | 1.10B | 4.4813 |
Mannkind Corp Stock (MNKD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-27 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-11-24 | Iniziato | Truist | Buy |
| 2025-11-13 | Iniziato | Leerink Partners | Outperform |
| 2025-10-20 | Iniziato | Wells Fargo | Overweight |
| 2025-10-10 | Iniziato | Leerink Partners | Outperform |
| 2025-07-16 | Ripresa | H.C. Wainwright | Buy |
| 2025-04-10 | Iniziato | Mizuho | Outperform |
| 2025-02-10 | Iniziato | Wedbush | Outperform |
| 2024-12-20 | Iniziato | Wells Fargo | Overweight |
| 2024-12-19 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-09-09 | Ripresa | Leerink Partners | Outperform |
| 2024-06-13 | Iniziato | Rodman & Renshaw | Buy |
| 2023-10-10 | Iniziato | Wedbush | Outperform |
| 2021-05-14 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-12-24 | Iniziato | Oppenheimer | Outperform |
| 2019-10-25 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-05-14 | Iniziato | BTIG Research | Buy |
| 2019-03-04 | Iniziato | SVB Leerink | Outperform |
| 2019-02-22 | Iniziato | SVB Leerink | Outperform |
| 2018-02-28 | Downgrade | Maxim Group | Hold → Sell |
| 2017-11-01 | Downgrade | Maxim Group | Buy → Hold |
| 2017-10-10 | Iniziato | H.C. Wainwright | Buy |
| 2017-10-06 | Reiterato | Maxim Group | Buy |
| 2017-08-11 | Iniziato | Maxim Group | Buy |
| 2016-05-10 | Reiterato | Piper Jaffray | Underweight |
| 2016-05-10 | Reiterato | RBC Capital Mkts | Underperform |
| 2016-01-06 | Reiterato | Piper Jaffray | Underweight |
| 2016-01-06 | Reiterato | RBC Capital Mkts | Underperform |
| 2015-11-04 | Downgrade | RBC Capital Mkts | Outperform → Underperform |
| 2015-09-09 | Downgrade | Piper Jaffray | Neutral → Underweight |
| 2015-08-03 | Reiterato | RBC Capital Mkts | Outperform |
| 2015-05-11 | Downgrade | JP Morgan | Neutral → Underweight |
| 2015-05-11 | Reiterato | MLV & Co | Hold |
| 2015-04-16 | Reiterato | RBC Capital Mkts | Outperform |
Mostra tutto
Mannkind Corp Borsa (MNKD) Ultime notizie
Wells Fargo Raises its Price Target on MannKind (MNKD) to $10 - Insider Monkey
MNKD stock records biggest single-day gains in over 5 years, breaches a key technical milestone – what’s driving this rally? - MSN
[144] MANNKIND CORP SEC Filing - Stock Titan
10 Best Penny Stocks to Buy Before They Explode - Insider Monkey
State Street (NASDAQ: MNKD) holds 18.68M shares, 6.1% stake - Stock Titan
MannKind Corp stock (US5638651064): Q1 2026 earnings miss on EPS, revenue up 15% - AD HOC NEWS
The $59B Quiet Shift Reshaping How Patients Access Care - Benzinga
H.C. Wainwright and Wells Fargo Lift MannKind (MNKD) Price Targets - Insider Monkey
TradingKey - TradingKey
5 Best US Stocks Under $5 to Buy - Insider Monkey
MNKD Technical Analysis & Stock Price Forecast - Intellectia AI
MNKD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Q1 2026 MannKind Corp Earnings Call Transcript - GuruFocus
Wall Street Zen Downgrades MannKind (NASDAQ:MNKD) to Sell - MarketBeat
MannKind (MNKD) CEO clarifies 100,000-share Form 4 error in amendment - Stock Titan
MannKind (MNKD) Is Up 25.4% After Mixed Q1 Results and Expanded United Therapeutics Partnership – What's Changed - Yahoo Finance
MNKD Maintained by RBC Capital -- Price Target Raised to $4.75 - GuruFocus
MNKD Maintains Overweight Rating -- Price Target Raised to $10.0 - GuruFocus
MannKind Corporation (NASDAQ:MNKD) Q1 2026 Earnings Call Transcript - Insider Monkey
MNKD Stock Price, Quote & Chart | MANNKIND CORP (NASDAQ:MNKD) - ChartMill
MannKind Q1 2026 slides: revenue up 15%, three catalysts ahead By Investing.com - Investing.com Canada
MannKind (NASDAQ:MNKD) Announces Earnings Results, Misses Estimates By $0.03 EPS - MarketBeat
MannKind Q1 Earnings Call Highlights - Yahoo Finance
MannKind Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
MannKind Q1 2026 slides: revenue up 15%, three catalysts ahead - Investing.com
Compared to Estimates, MannKind (MNKD) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Earnings call transcript: MannKind Q1 2026 sees revenue growth, stock surges - Investing.com
MannKind (MNKD) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
MannKind Corp (NASDAQ:MNKD) Q1 2026 Revenue Miss and Wider EPS Loss Overshadow Strong Pipeline Progress - ChartMill
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
MannKind: Q1 Earnings Snapshot - Barchart.com
Revenue growth but net loss for MannKind (NASDAQ: MNKD) in Q1 2026 - Stock Titan
MannKind heads into two FDA decisions after posting $90.2M in Q1 - Stock Titan
MannKind (NASDAQ: MNKD) Q1 2026 revenue rises 15% as Furoscix ramps - Stock Titan
MNKD Stock Records Biggest Single-Day Gains In Over 5 Years, Breaches A Key Technical Milestone – What’s Driving This Rally? - Stocktwits
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Keep an eye on the top gainers and losers in Wednesday's session. - ChartMill
Why is MannKind stock surging today? By Investing.com - Investing.com Canada
Why is MannKind stock surging today? - Investing.com
MannKind stock surges on United Therapeutics partnership deal - Investing.com
Davita, Bloomin' Brands, Compass And Other Big Stocks Moving Higher On Wednesday - Benzinga
Wednesday's session: gap up and gap down stocks - ChartMill
MannKind advances inhaled ralinepag program for lung diseases - Stock Titan
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
MannKind develops inhaled ralinepag formulation for United Therapeutics By Investing.com - Investing.com South Africa
MannKind develops inhaled ralinepag formulation for United Therapeutics - Investing.com
At least five PDUFA dates on FDA’s May docket - BioCentury
MNKD Technical Analysis | Trend, Signals & Chart Patterns | MANNKIND CORP (NASDAQ:MNKD) - ChartMill
Is MannKind Corporation (MNKD) The Best Fundamentally Strong Penny Stock to Invest In Now? - Insider Monkey
5 Best Fundamentally Strong Penny Stocks to Invest In Now - Insider Monkey
MannKind settles $36.3M convertible notes with cash, shares - Investing.com
Mannkind Corp Azioni (MNKD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):